CATX
Perspective Therapeutics Inc.
2.40$
-8.2%
vs. previous close
Closing price · As of: Oct 6, 2026
Statements
Cash Flow
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2010 | 2010 | 2011 | 2011 | 2012 | 2012 | 2013 | 2013 | 2014 | 2014 | 2015 | 2015 | 2016 | 2016 | 2017 | 2017 | 2018 | 2018 | 2019 | 2019 | 2020 | 2020 | 2021 | 2021 | 2022 | 2022 | 2023 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -50.8% | -50.8% | -46.2% | -46.2% | -48.3% | -48.3% | -67.5% | -67.5% | -76.5% | -76.5% | -76.5% | -76.5% | -81.4% | -81.4% | -120.0% | -120.0% | -96.4% | -69.0% | -69.0% | -37.6% | -37.6% | -28.2% | -28.2% | -71.4% | -71.4% | -192.1% | -171.3% | -2,574.1% | -1,258.2% | -9,330.8% | |
| 18.9% | 18.0% | 17.0% | 17.0% | 16.7% | 16.7% | 16.3% | 16.3% | 16.2% | 16.2% | 12.5% | 12.5% | 9.9% | 9.9% | 1.4% | 1.4% | 1.4% | 1.9% | 1.9% | 1.5% | 1.5% | 1.5% | 1.5% | 2.3% | 2.3% | 6.0% | 4.8% | 68.8% | 158.6% | 367.8% | |
| 5.2% | 5.2% | 4.6% | 4.6% | 3.4% | 3.4% | 2.4% | 2.4% | 4.4% | 4.4% | 4.5% | 4.5% | 6.1% | 6.1% | 7.8% | 7.8% | 10.2% | 5.7% | 5.7% | 5.1% | 5.1% | 3.8% | 3.8% | 10.1% | 10.1% | 14.9% | 18.9% | 260.7% | 370.5% | 1,014.3% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 4.4% | – | 4.0% | – | 10.1% | – | – | – | – | – | |
| 0.5% | 0.5% | -12.7% | -13.2% | 1.1% | 1.1% | 1.5% | 1.5% | 9.2% | 9.2% | -7.8% | -7.7% | 8.4% | 8.4% | 0.4% | 0.4% | 3.7% | -7.1% | -7.1% | -8.6% | -8.6% | -0.7% | -0.7% | -17.1% | -17.1% | -32.1% | 4.8% | 203.6% | 2,188.0% | 190.2% | |
| 0.6% | 0.6% | 3.0% | 3.0% | 1.9% | 1.9% | 0.3% | 0.3% | 0.9% | 0.9% | 3.3% | 2.9% | 10.3% | 10.0% | 11.5% | 11.5% | 5.7% | 6.1% | 6.1% | 2.8% | 2.8% | 3.8% | 3.8% | 2.5% | 2.5% | 5.2% | 4.3% | 74.8% | 3,742.4% | 1,442.2% | |
| – | 31.1% | – | -3.0% | – | -1.9% | – | -0.3% | – | -366.0% | – | 17.0% | – | 183.6% | – | 31.8% | – | 5.5% | – | -3.0% | -3.0% | -4.1% | -4.1% | – | -2.6% | -535.3% | – | 1,699.7% | -15,057.2% | 4,663.8% | |
| 0.7% | 0.7% | 0.2% | 0.2% | 0.2% | 0.2% | 0.2% | 0.2% | 0.3% | 0.3% | 0.2% | 0.2% | 0.2% | 0.2% | 0.2% | 0.2% | 0.2% | 0.2% | 0.2% | 0.1% | 0.1% | 0.1% | 0.1% | 0.0% | 0.0% | – | – | – | – | – | |
| – | -2.0% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -4.7% | -3.3% | -5.9% | |
| -5.1% | -5.1% | 57.5% | 57.5% | 61.2% | 61.2% | 72.8% | 72.8% | 555.8% | 555.8% | 6.2% | 6.2% | 0.8% | 0.8% | -0.2% | -0.2% | 8.8% | 100.8% | 100.8% | 10.3% | 10.3% | 643.4% | 643.4% | 0.5% | 0.5% | 0.5% | 0.8% | 54.7% | 19,902.7% | 1,165.7% | |
| -24.8% | -24.8% | 8.3% | 8.3% | 11.1% | 11.1% | 5.0% | 5.0% | 113.3% | 113.3% | -53.3% | -53.3% | 103.0% | 103.0% | -88.4% | -88.4% | -56.3% | 37.3% | 37.3% | -30.3% | -30.3% | 611.1% | 611.1% | -73.5% | -73.5% | -146.6% | 2.6% | -819.7% | 3,587.3% | -3,501.2% | |
| -51.5% | -51.5% | -49.2% | -49.2% | -50.1% | -50.1% | -67.8% | -67.8% | -77.4% | -77.4% | -79.7% | -79.3% | -91.7% | -91.5% | -131.5% | -131.5% | -102.1% | -75.1% | -75.1% | -40.4% | -40.4% | -32.0% | -32.0% | -73.9% | -73.9% | -197.3% | -175.6% | -2,648.9% | -5,000.6% | -10,773.0% |
Data as of: October 6, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.